Healthcare
Live Price
Offline$24.05
+2.08% today
Window Change
+11.47%
Window
Nov 6, 2025 → Jun 22, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 154 bars · Nov 6, 2025 → Jun 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Evommune, Inc. (EVMN) is a Healthcare stock with a market cap of $310.00M and listed on NYSE. The stock last traded around $24.05 and up 11.5% across the available one-year price window (Nov 6, 2025 → Jun 22, 2026). Baseline metrics include revenue growth of +85.7%, EPS growth of +4.0%, a dividend yield of 0.0%. What stands out right now is revenue +85.7%, EPS +4.0%, free cash flow -31.6% with operating margin -623.6% and ROIC -39.0%. Valuation already assumes a fairly strong business story at price/sales 23.9. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines EVMN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
EVMN
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
EVMN Max Drawdown
-37.50%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for EVMN and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.